在与布里斯托尔·迈尔斯·斯奎布合作进行癌症免疫治疗后,BioNTECH的库存猛增了20.2%。 BioNTech's stock surged 20.2% after partnering with Bristol Myers Squibb for cancer immunotherapy.

现在有几家医疗保健和生物技术股票受到关注,其中蓝图药品,诺沃诺迪斯克和巴塞尔医疗集团是增长股票的领导者. Several healthcare and biotech stocks are in the spotlight today, with Blueprint Medicines, Novo Nordisk, and Basel Medical Group leading growth stocks. 在Bristol Myers Squibb与布里斯托尔·迈尔斯·斯奎布合作进行癌症免疫治疗后,BioNTECH的库存猛增了20.2%。 BioNTech's stock surged 20.2% post-its partnership with Bristol Myers Squibb for cancer immunotherapy. 联合健康集团,Alphabet和Tempus AI是医疗保健行业的顶级交易商,而MarketBeat则强调生物技术股票,如Lyra Therapeutics和BioNTech. UnitedHealth Group, Alphabet, and Tempus AI are top healthcare traders, while MarketBeat highlights biotech stocks like Lyra Therapeutics and BioNTech. The Motley Fool 推荐 Amgen、Vertex Pharmaceuticals 和 Summit Therapeutics，因为它们有前途的管道和增长潜力。 The Motley Fool recommends Amgen, Vertex Pharmaceuticals, and Summit Therapeutics for their promising pipelines and growth potential.